SG11202103026YA - Peptides for use in treating and preventing skin aging and photo-aging - Google Patents
Peptides for use in treating and preventing skin aging and photo-agingInfo
- Publication number
- SG11202103026YA SG11202103026YA SG11202103026YA SG11202103026YA SG11202103026YA SG 11202103026Y A SG11202103026Y A SG 11202103026YA SG 11202103026Y A SG11202103026Y A SG 11202103026YA SG 11202103026Y A SG11202103026Y A SG 11202103026YA SG 11202103026Y A SG11202103026Y A SG 11202103026YA
- Authority
- SG
- Singapore
- Prior art keywords
- aging
- peptides
- photo
- treating
- preventing skin
- Prior art date
Links
- 206010051246 Photodermatosis Diseases 0.000 title 1
- 230000008845 photoaging Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000009759 skin aging Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102018000009384A IT201800009384A1 (it) | 2018-10-11 | 2018-10-11 | Peptide for cosmetic application |
| PCT/IB2019/058641 WO2020075108A1 (en) | 2018-10-11 | 2019-10-10 | Peptides for use in treating and preventing skin aging and photo-aging |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202103026YA true SG11202103026YA (en) | 2021-04-29 |
Family
ID=65010824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202103026YA SG11202103026YA (en) | 2018-10-11 | 2019-10-10 | Peptides for use in treating and preventing skin aging and photo-aging |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210395305A1 (enExample) |
| EP (1) | EP3863728A1 (enExample) |
| JP (1) | JP2022508676A (enExample) |
| KR (1) | KR20210075098A (enExample) |
| CN (1) | CN112823039A (enExample) |
| AU (1) | AU2019357261A1 (enExample) |
| BR (1) | BR112021006742A2 (enExample) |
| CA (1) | CA3115025A1 (enExample) |
| EA (1) | EA202190888A1 (enExample) |
| IL (1) | IL282064B (enExample) |
| IT (1) | IT201800009384A1 (enExample) |
| SG (1) | SG11202103026YA (enExample) |
| WO (1) | WO2020075108A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202000020287A1 (it) * | 2020-08-20 | 2022-02-20 | Colosseum Combinatorial Chemistry Centre For Tech Societa A Responsabilita Limitata In Forma Abbrevi | Peptide per applicazioni terapeutiche in campo dermatologico |
| KR102774179B1 (ko) * | 2021-09-29 | 2025-03-04 | (주)케어젠 | 항노화 활성을 갖는 펩타이드 및 이의 용도 |
| KR102726837B1 (ko) * | 2021-09-29 | 2024-11-07 | (주)케어젠 | 항노화 활성을 갖는 펩타이드 및 이의 용도 |
| KR102736940B1 (ko) * | 2021-09-30 | 2024-12-03 | (주)케어젠 | 항노화 활성을 갖는 펩타이드 및 이의 용도 |
| KR102877905B1 (ko) * | 2021-09-30 | 2025-10-30 | (주)케어젠 | 항노화 활성을 갖는 펩타이드 및 이의 용도 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7196055B2 (en) | 1994-08-31 | 2007-03-27 | Trustees Of Boston University | Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor |
| GB9616105D0 (en) * | 1996-07-31 | 1996-09-11 | Univ Kingston | TrkA binding site of NGF |
| AU7154698A (en) * | 1997-04-25 | 1998-11-24 | Genentech Inc. | Ngf variants |
| US6664230B1 (en) * | 2000-08-24 | 2003-12-16 | The Regents Of The University Of California | Orally administered peptides to ameliorate atherosclerosis |
| US6919426B2 (en) | 2002-09-19 | 2005-07-19 | Amgen Inc. | Peptides and related molecules that modulate nerve growth factor activity |
| MEP31508A (hr) | 2003-07-15 | 2010-10-10 | Amgen Inc | Humana anti-ngf neutrališuća antitijela kao selektivni ihibitori ngf signalne kaskade |
| ME00226B (me) | 2004-07-15 | 2011-02-10 | Medarex Llc | Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade |
| EP2144615A4 (en) * | 2007-04-06 | 2011-02-16 | Kai Pharmaceuticals Inc | METHOD OF USE OF GAMMA INHIBITOR COMPOUNDS FOR PAIN LIFTING |
| IT1394690B1 (it) * | 2008-10-23 | 2012-07-13 | Carli De | Metodo di trattamento dermocosmetico della cute mediante applicazione di composizioni contenenti ngf. |
| KR101520333B1 (ko) * | 2008-11-25 | 2015-05-14 | (주)아모레퍼시픽 | 글루타밀아미도에틸 인돌을 함유하는 항노화용 화장료 조성물 |
| EP2547365A1 (en) | 2010-03-17 | 2013-01-23 | Abbott Research B.V. | Anti-nerve growth factor (ngf) antibody compositions |
| IE20100174A1 (en) * | 2010-03-25 | 2012-02-29 | Trinity College Dublin | Transdermal administration of peptides |
| FR2961814B1 (fr) * | 2010-06-29 | 2014-09-26 | Isp Investments Inc | Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant. |
| JP6042343B2 (ja) * | 2010-11-18 | 2016-12-14 | スティーヴン ヨーリン | 毛髪成長のための組成物及び方法 |
| ITRM20110574A1 (it) * | 2011-11-02 | 2013-05-03 | Sampo S R L | Preparato topico per indurre la pigmentazione cutanea e per il trattamento di discromie cutanee e vitiligine. |
| EP3352853B1 (en) * | 2015-09-22 | 2022-09-21 | Johnson & Johnson Consumer Inc. | Methods for enhancing topical application of a benefit agent |
| KR20170049299A (ko) * | 2015-10-28 | 2017-05-10 | 경상대학교산학협력단 | 성장인자와 사이토카인을 포함하는 조성물 |
| CN107286233B (zh) * | 2016-04-13 | 2020-11-06 | 舒泰神（北京）生物制药股份有限公司 | 低痛神经生长因子突变体 |
| CN107973848B (zh) * | 2017-12-28 | 2020-10-16 | 未名生物医药有限公司 | 一种从混合物中分离天然序列神经生长因子的方法 |
-
2018
- 2018-10-11 IT IT102018000009384A patent/IT201800009384A1/it unknown
-
2019
- 2019-10-10 AU AU2019357261A patent/AU2019357261A1/en not_active Abandoned
- 2019-10-10 EP EP19784151.3A patent/EP3863728A1/en active Pending
- 2019-10-10 IL IL282064A patent/IL282064B/en unknown
- 2019-10-10 EA EA202190888A patent/EA202190888A1/ru unknown
- 2019-10-10 WO PCT/IB2019/058641 patent/WO2020075108A1/en not_active Ceased
- 2019-10-10 SG SG11202103026YA patent/SG11202103026YA/en unknown
- 2019-10-10 KR KR1020217011590A patent/KR20210075098A/ko not_active Withdrawn
- 2019-10-10 JP JP2021544961A patent/JP2022508676A/ja active Pending
- 2019-10-10 BR BR112021006742-6A patent/BR112021006742A2/pt not_active Application Discontinuation
- 2019-10-10 US US17/284,343 patent/US20210395305A1/en not_active Abandoned
- 2019-10-10 CA CA3115025A patent/CA3115025A1/en active Pending
- 2019-10-10 CN CN201980066612.1A patent/CN112823039A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022508676A (ja) | 2022-01-19 |
| EA202190888A1 (ru) | 2021-07-07 |
| KR20210075098A (ko) | 2021-06-22 |
| EP3863728A1 (en) | 2021-08-18 |
| AU2019357261A1 (en) | 2021-05-13 |
| BR112021006742A2 (pt) | 2021-09-21 |
| IL282064A (en) | 2021-05-31 |
| WO2020075108A1 (en) | 2020-04-16 |
| US20210395305A1 (en) | 2021-12-23 |
| IL282064B (en) | 2022-09-01 |
| IT201800009384A1 (it) | 2020-04-11 |
| CA3115025A1 (en) | 2020-04-16 |
| CN112823039A (zh) | 2021-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282064A (en) | Peptides for use in the treatment and prevention of skin aging and photoaging | |
| IL282871A (en) | Systems and methods for skin care | |
| IL277343B1 (en) | "CD47-binding factors and their uses in the treatment of diseases" | |
| IL258787A (en) | Peptides and peptide deletions in combination with t-cell activating agents and/or checkpoint inhibitors for cancer treatment | |
| ZA202104737B (en) | Methods and compositions for treating skin and hair disorders | |
| PL3471836T3 (pl) | Preparaty dermatologiczne do utrzymywania i/lub przywracania zdrowej mikrobioty skóry | |
| IL281605A (en) | B*44 restricted peptides for use in immunotherapy against cancers and related methods | |
| ZA201704726B (en) | Peptides and their use in the treatment of skin | |
| PL3758730T3 (pl) | Peptydy i kompozycje do stosowania w kosmetyce i medycynie | |
| PL3908252T3 (pl) | Peptydy i kompozycje do stosowania w kosmetyce | |
| GB2588994B (en) | Combar for skin and hair treatment | |
| IL275340A (en) | Peptides and other active compounds to treat pain and increase pain sensitivity | |
| HUE048547T2 (hu) | Készülékek a bõr erek kezelésére | |
| IL266849A (en) | System and method for optical plethysmography | |
| IL276920A (en) | Hair coloring compound and method | |
| EP3947418C0 (en) | PEPTIDES AND THEIR USE | |
| GB201810635D0 (en) | Peptides and cancer treatment | |
| IL277689A (en) | Application of short peptides extracted from PEDF in tendon healing | |
| SG11201802955VA (en) | Peptides of use in the preventive and curative treatment of alopecia | |
| IL268844A (en) | Peptides and methods of treating dystrophy-related diseases by them | |
| IL259395B (en) | A cosmetic compound for use in the treatment and prevention of skin with acne | |
| IL265614A (en) | Skin and tissue protection device for cold cosmetic treatments | |
| EP3288963A4 (en) | Pink1 c-terminal domain polypeptide and methods using the same in cancer treatment | |
| IL277112A (en) | Compounds for inhibiting protein degradation and methods of use thereof in the treatment of cancer | |
| ZA201802772B (en) | Hair treatment composition and method |